Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GENTEX CORPGNTX · Entity 3954 | General Counsel | February 17, 2026 | February 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GENTEX CORP
Report date February 17, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 67,702 |
Reported balance
After 2026-02-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-17 · Grant · Acquired 25,782 · Balance 67,702 F1: 25,782 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. F2: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan |
| Common StockSEC Table I · non-derivative | Direct | 56,210 |
Reported balance
After 2026-02-17 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-02-17 · Tax withholding · Disposed 11,492 · Balance 56,210 |
| Common StockSEC Table I · non-derivative | Direct | 53,303 |
Reported balance
After 2026-02-17 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-02-17 · Tax withholding · Disposed 2,907 · Balance 53,303 |
| Common StockSEC Table I · non-derivative | Direct | 46,158 |
Reported balance
After 2026-02-17 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-02-17 · Sale · Disposed 7,145 · Balance 46,158 |
| Common StockSEC Table I · non-derivative | Direct | 44,279 |
Reported balance
After 2026-02-17 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2026-02-17 · Sale · Disposed 1,879 · Balance 44,279 |
| Common StockSEC Table I · non-derivative | Direct | 55,279 |
Reported balance
After 2026-02-19 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2026-02-19 · Grant · Acquired 11,000 · Balance 55,279 F3: These shares vest 100% three years from grant award date. |
Filing footnotes · ownership attribution and instrument terms
F1: 25,782 shares are performance-based shares where the total number of shares granted were based on long term performance incentives.
F2: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan
F3: These shares vest 100% three years from grant award date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2026 Filed Feb 19, 2026 21:39 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001651517-26-000001 · primarydocument.xml · nonDerivative · entry 6 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,279 F3 · kind: These shares vest 100% three years from grant award date. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:39 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 1,879 | $24.73 | $46,468.05 |
DisclosureSEC source: 0001651517-26-000001 · primarydocument.xml · nonDerivative · entry 5 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,279 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:39 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 7,145 | $24.73 | $176,697.28 |
DisclosureSEC source: 0001651517-26-000001 · primarydocument.xml · nonDerivative · entry 4 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,158 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:39 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 2,907 | $24.89 | $72,355.23 |
DisclosureSEC source: 0001651517-26-000001 · primarydocument.xml · nonDerivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,303 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:39 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 11,492 | $24.89 | $286,035.88 |
DisclosureSEC source: 0001651517-26-000001 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,210 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:39 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 25,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001651517-26-000001 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,702 F1 · kind: 25,782 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. F2 · balance_after: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 16:11 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 8,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-001462 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,852 F1 · shares: These shares vest 100% three years from grant award date. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:11 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 2,573 | $24.62 | $63,354.98 |
DisclosureSEC source: 0001562180-25-001303 · primarydocument.xml · nonDerivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,482 F3 · price: This transaction was executed in multiple trades at prices ranging from $24.36 to $24.78. The price reported above reflects the weighted average price. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:11 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 5,042 | $24.62 | $124,149.17 |
DisclosureSEC source: 0001562180-25-001303 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,055 F3 · price: This transaction was executed in multiple trades at prices ranging from $24.36 to $24.78. The price reported above reflects the weighted average price. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:11 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 10,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-001303 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,097 F1 · kind: 13,085 shares are performance based shares where the total number of shares granted were based on long term performance incentives. F2 · balance_after: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:13 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 12,500 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001562180-24-001472 · primarydocument.xml · derivative · entry 6 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2028-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:13 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 12,500 | $35.00 | $437,450.00 |
DisclosureSEC source: 0001562180-24-001472 · primarydocument.xml · nonDerivative · entry 5 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,949 F3 · price: This transaction was executed in multiple trades at prices ranging from $34.96 to $35.05. The price reported above reflects the weighted average price. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:13 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 12,500 | $22.94 | $286,750.00 |
DisclosureSEC source: 0001562180-24-001472 · primarydocument.xml · nonDerivative · entry 4 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:13 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 2,576 | $35.01 | $90,188.59 |
DisclosureSEC source: 0001562180-24-001472 · primarydocument.xml · nonDerivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,949 F2 · price: This transaction was executed in multiple trades at prices ranging from $34.72 to $35.14. The price reported above reflects the weighted average price. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:13 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 3,708 | $35.01 | $129,821.16 |
DisclosureSEC source: 0001562180-24-001472 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,525 F2 · price: This transaction was executed in multiple trades at prices ranging from $34.72 to $35.14. The price reported above reflects the weighted average price. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:13 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 7,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001472 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,233 F1 · kind: 7,636 shares are performance based shares where the total number of shares granted were based on long term performance incentives. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 19:40 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 6,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001372 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,597 F1 · shares: These shares vest 100% three years from grant award date. F2 · balance_after: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| February 21, 2023 Filed Feb 21, 2023 22:41 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 4,325 | $28.29 | $122,362.47 |
DisclosureSEC source: 0001562180-23-001585 · primarydocument.xml · nonDerivative · entry 4 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,631 F3 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $28.02 to $28.60. The price reported above reflects the weighted average price. Read SEC document |
| February 21, 2023 Filed Feb 21, 2023 22:41 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 5,570 | $28.29 | $157,585.88 |
DisclosureSEC source: 0001562180-23-001585 · primarydocument.xml · nonDerivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,956 F3 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $28.02 to $28.60. The price reported above reflects the weighted average price. Read SEC document |
| February 21, 2023 Filed Feb 21, 2023 22:41 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 5,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001585 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,526 F2 · kind: 5,570 shares are performance based shares where the total number of shares granted were based on long term performance incentives. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:41 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 6,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001585 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,956 F1 · shares: These shares vest 100% three years from grant award date. Read SEC document |
| January 04, 2023 Filed Jan 4, 2023 21:36 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,580 | $0.00 Strike: $14.70 | $0.00 |
DisclosureSEC source: 0001562180-23-000130 · primarydocument.xml · derivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,580 shares Expires 2023-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date. Read SEC document |
| January 04, 2023 Filed Jan 4, 2023 21:36 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 4,580 | $28.00 | $128,240.00 |
DisclosureSEC source: 0001562180-23-000130 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,290 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Column 5 reflects the acquisition of 865 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| January 04, 2023 Filed Jan 4, 2023 21:36 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 4,580 | $14.70 | $67,326.00 |
DisclosureSEC source: 0001562180-23-000130 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:58 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 8,797 | $30.36 | $267,098.03 |
DisclosureSEC source: 0001562180-22-001715 · primarydocument.xml · nonDerivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,425 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:58 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 8,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001715 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,222 F3 · kind: 8,797 shares are performance based shares where the total number of shares granted were based on long term performance incentives as disclosed on Form 10K filed on February 23, 2022. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:58 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 4,958 | $30.36 | $150,536.78 |
DisclosureSEC source: 0001562180-22-001715 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,425 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 13:16 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 5,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001656 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,383 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 17:38 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 1,820 | $31.32 | $57,004.58 |
DisclosureSEC source: 0001562180-22-001534 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,836 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $31.16 to $31.48. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 91 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:38 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 8,000 | $31.50 | $251,985.60 |
DisclosureSEC source: 0001562180-22-001534 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,656 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $31.06 to $31.84. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 91 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| October 25, 2021 Filed Oct 25, 2021 20:36 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,580 | $0.00 Strike: $16.01 | $0.00 |
DisclosureSEC source: 0001562180-21-006634 · primarydocument.xml · derivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,580 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date. Read SEC document |
| October 25, 2021 Filed Oct 25, 2021 20:36 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 9,224 | $34.27 | $316,106.48 |
DisclosureSEC source: 0001562180-21-006634 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,565 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F1 · balance_after: Column 5 reflects the acquisition of 582 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| October 25, 2021 Filed Oct 25, 2021 20:36 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 4,580 | $16.01 | $73,325.80 |
DisclosureSEC source: 0001562180-21-006634 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Column 5 reflects the acquisition of 582 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 19:23 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 1,650 | $35.57 | $58,689.18 |
DisclosureSEC source: 0001562180-21-001438 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,627 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.34 to $35.85. The price reported above reflects the weighted average price. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 17:40 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 5,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001360 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,277 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 19:56 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 1,512 | $35.73 | $54,028.90 |
DisclosureSEC source: 0001562180-21-001187 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,725 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.53 to $35.88. The price reported above reflects the weighted average price. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 22:26 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 1,650 | $33.93 | $55,989.78 |
DisclosureSEC source: 0001562180-21-000049 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,237 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $33.74 to $34.06. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 93 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 20:55 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 1,085 | $30.00 | $32,550.00 |
DisclosureSEC source: 0001562180-20-006591 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,794 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Column 5 reflects the acquisition of 116 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 23:54 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 117 | $21.42 | $2,506.14 |
DisclosureSEC source: 0001562180-20-004726 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,763 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 16:21 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 675 | $18.53 | $12,507.75 |
DisclosureSEC source: 0001562180-20-002767 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,646 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 20:09 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 4,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001548 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,971 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation Restricted Stock Plan, which is a Rule 16B-3 Plan. Read SEC document |
| December 27, 2019 Filed Dec 30, 2019 14:58 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 101 | $24.65 | $2,489.65 |
DisclosureSEC source: 0001562180-19-006280 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,646 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| September 27, 2019 Filed Sep 30, 2019 21:52 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 106 | $23.52 | $2,493.12 |
DisclosureSEC source: 0001562180-19-004973 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,545 Read SEC document |
| July 22, 2019 Filed Jul 22, 2019 20:05 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 4,798 | $18.31 Strike: $18.31 | $87,851.38 |
DisclosureSEC source: 0001562180-19-004020 · primarydocument.xml · derivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,798 shares Expires 2019-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options are fully vested. Read SEC document |
| July 22, 2019 Filed Jul 22, 2019 20:05 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 4,798 | $25.32 | $121,485.36 |
DisclosureSEC source: 0001562180-19-004020 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,439 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 22, 2019 Filed Jul 22, 2019 20:05 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 4,798 | $18.31 | $87,851.38 |
DisclosureSEC source: 0001562180-19-004020 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2019 Filed Jul 1, 2019 18:24 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 3,522 | $18.31 Strike: $18.31 | $64,487.82 |
DisclosureSEC source: 0001562180-19-003713 · primarydocument.xml · derivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,798 Underlying: Common Stock · 3,522 shares Expires 2019-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options are fully vested. Read SEC document |
| June 28, 2019 Filed Jul 1, 2019 18:24 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 120 | $20.92 | $2,510.40 |
DisclosureSEC source: 0001562180-19-003713 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,439 F2 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| June 28, 2019 Filed Jul 1, 2019 18:24 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 3,522 | $25.00 | $88,050.00 |
DisclosureSEC source: 0001562180-19-003713 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,319 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 29, 2019 Filed Apr 1, 2019 14:12 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 711 | $17.58 | $12,499.38 |
DisclosureSEC source: 0001562180-19-002060 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,319 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.